Cargando…
Usefulness of the MESH score in a European hepatocellular carcinoma cohort
The Barcelona Clinic Liver Cancer classification is the most widely - used hepatocellular carcinoma (HCC) staging system because it is simple, precise and linked to a treatment algorithm based on randomized studies. But each group includes a broad spectrum of tumors, with limited therapeutic options...
Autores principales: | Adhoute, Xavier, Pénaranda, Guillaume, Raoul, Jean-Luc, Bourlière, Marc |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5440775/ https://www.ncbi.nlm.nih.gov/pubmed/28596819 http://dx.doi.org/10.4254/wjh.v9.i15.711 |
Ejemplares similares
-
“Six-and-twelve” score for outcome prediction of hepatocellular carcinoma following transarterial chemoembolization. In-depth analysis from a multicenter French cohort
por: Adhoute, Xavier, et al.
Publicado: (2020) -
Barcelona clinic liver cancer nomogram and others staging/scoring systems in a French hepatocellular carcinoma cohort
por: Adhoute, Xavier, et al.
Publicado: (2017) -
Expected outcomes and patients’ selection before chemoembolization—“Six-and-Twelve or Pre-TACE-Predict” scores may help clinicians: Real-life French cohorts results
por: Adhoute, Xavier, et al.
Publicado: (2021) -
Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma: Real-life Data on Liver Disease, Treatment and Prognosis
por: Adhoute, Xavier, et al.
Publicado: (2023) -
How to assess the efficacy or failure of targeted therapy: Deciding when to stop sorafenib in hepatocellular carcinoma
por: Raoul, Jean-Luc, et al.
Publicado: (2016)